Roquette and Qualicaps combine to expand global footprint

Qualicaps manufactures hard capsules and pharmaceutical-related equipment and is the third-largest producer for oral dosage solutions.

The company is a ‘renowned global player, relying on high-quality products and a strong innovation pipeline’. It has a workforce of 1,400 employees located in different sites in Asia, Europe, and the Americas.

Roquette is a family-owned global leader in plant-based ingredients and a leading provider of pharmaceutical excipients. The company currently operates in more than 100 countries, has a turnover of around €5 billion and, with this acquisition, will employ around 10,000 people worldwide.

Expanding Roquette’s global footprint in the pharma business

This strategic investment offers Roquette the ability to expand the global footprint of its pharmaceutical business, as well as enrich its offerings of oral dosage solutions. Roquette’s deep knowledge and expertise in the development of pharmaceutical excipients will be further enhanced by Qualicaps’ expertise in capsules, as well as by their assets and infrastructure.

Roquette said that with the acquisition it aims to consolidate its leadership position while serving customers, and the market, with ‘superior solutions and an expanded choice’.

Hard and soft capsules, filler and binders, disintegrants among other solutions will be on offer through the combined business.

Qualicaps is an ideal addition to Roquette thanks to its shared commitment to innovation, quality and excellence. Its global footprint, with manufacturing and R&D sites in Japan, Spain, Romania, Canada, the USA, and Brazil, will allow Roquette to expand its presence and be closer to its customers and markets.

Leave a Reply

Your email address will not be published. Required fields are marked *